Takeda, Mylan Reach Agreement Over Prevacid Generic
The settlement agreement, signed by U.S. District Judge Joel A. Pisano, dismisses Mylan as a defendant but a unit of the drugmaker, Mylan Pharmaceuticals Inc., remains in the suit.
Takeda accuses Mylan of infringing its two patents covering Prevacid by filing an abbreviated new drug application to get U.S. Food and...
Already a subscriber? Click here to login